Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$15.45 0.14 | 0.91%
12/02/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 10.45B 8.21B 5.77B 3.48B
Cost of Sales 2.23B 1.98B 1.70B 876.00M
Gross Operating Profit 8.22B 6.23B 4.07B 2.60B
Selling, General, and Administrative Expenses 2.70B 2.03B 1.31B 756.10M
Research & Development 334.40M 246.00M 156.80M 79.10M
Operating Income before D & A (EBITDA) 5.18B 3.95B 2.61B 1.77B
Depreciation & Amortization 2.77B 1.81B 2.11B 1.02B
Interest Income 3.30M 5.00M 8.00M 6.00M
Other Income - Net -138.30M 26.70M -75.80M -71.60M
Special Income / Charges -504.50M 227.70M -440.80M -326.50M
Total Income Before Interest Expenses (EBIT) 1.41B 2.02B -470.10M 87.40M
Interest Expense 1.56B 971.00M 844.30M 481.60M
Pre-Tax Income -155.30M 1.05B -1.31B -394.20M
Income Taxes 132.50M 174.20M -450.80M -278.20M
Minority Interest 3.90M -1.30M 2.50M 0.00
Net Income From Continuing Operations -287.80M 879.40M -863.60M -116.00M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -287.80M 879.40M -863.60M -116.00M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -291.70M 880.70M -866.10M -116.00M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
578.60M 1.03B 39.20M 477.60M
Preferred Dividends
Net Income Available To Common -287.80M 879.40M -863.60M -116.00M
Basic EPS from Continuing Ops. -0.85 2.63 -2.70 -0.38
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.85 2.63 -2.70 -0.38
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.85 2.63 -2.70 -0.38
Basic Normalized Net Income/Share 1.71 3.09 0.12 1.56
EPS fr Continuing Ops. -0.85 2.58 -2.70 -0.38
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.85 2.58 -2.70 -0.38
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.85 2.58 -2.70 -0.38
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.71 3.03 0.12 1.56
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases

Partner Headlines for VRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter